Article By:
KKD Healthcare Analytics
Tuesday, June 6, 2017 3:37 PM EDT
Sonoma Pharmaceuticals operates in dermatological care segment, which is considered rather low-risk area of pharmacology. The valuations of the company are also on the cheaper side, which is expected to reward the early spotters at the later stage.
In this article: SNOA